GlaxoSmithKline Opens Door to Data on Research
Published October 11, 2012 by OSP
Glaxo is the first major pharma company to move towards transparency in clinical trials and might set a precedent in the industry. On Thursday, the company will announce that research data from clinical trials, including the protocol, will be available to researchers. However, those researchers will have to submit request to a Glaxo panel that will determine the validity of the request and not all clinical trials will be available for analysis.